Coldstream Capital Management Inc Bio Techne Corp Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 4,808 shares of TECH stock, worth $342,714. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,808

Previous 4,472 7.51%

Holding current value

$342,714

Previous $320,000 20.0%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$70.96 - $82.35 $23,842 - $27,669	336 Added 7.51%	4,808 $384,000
Q2 2024 Aug 07, 2024	BUY	$62.12 - $84.15 $12,610 - $17,082	203 Added 4.76%	4,472 $320,000
Q1 2024 May 13, 2024	SELL	$65.98 - $77.09 $10,226 - $11,948	-155 Reduced 3.5%	4,269 $300,000
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $35,131 - $52,016	665 Added 17.69%	4,424 $341,000
Q3 2023 Nov 02, 2023	SELL	$67.52 - $89.42 $25,320 - $33,532	-375 Reduced 9.07%	3,759 $255,000
Q2 2023 Aug 03, 2023	SELL	$73.76 - $85.98 $25,447 - $29,663	-345 Reduced 7.7%	4,134 $337,000
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $40,107 - $48,507	-560 Reduced 11.11%	4,479 $332,000
Q4 2022 Jan 10, 2023	BUY	$80.67 - $352.29 $309,772 - $1.35 Million	3,840 Added 320.27%	5,039 $0
Q2 2022 Aug 08, 2022	BUY	$322.67 - $449.65 $386,881 - $539,130	1,199 New	1,199 $416,000
Q2 2022 Aug 08, 2022	SELL	$322.67 - $449.65 $375,265 - $522,942	-1,163 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$353.85 - $487.79 $19,461 - $26,828	55 Added 4.96%	1,163 $503,000
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $505,414 - $581,766	1,108 New	1,108 $573,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Bio Techne Corp Transaction History